Trial intelligence / Profile preview

Estriol for Coital Pain in Postmenopausal Women

NCT03116022Phase 1Completed

Sponsor
Universidade de São Paulo
Start
Jun 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of estriol in dyspareunia (3 arms), sponsored by Universidade de São Paulo. Primary endpoint: Improvement in pain score at 12 weeks. Started Jun 2017; status: completed.

02

Drugs

estriol
03

Conditions

dyspareunia

Beyond the preview

Go deeper on NCT03116022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03116022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call